We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LAKE:NASDAQLakeland Industries, Inc. Analysis

Data as of 2026-07-23 - not real-time

$10.65

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Lakeland Industries is trading at $10.65, which sits below its 20‑day SMA of 11.26, 50‑day SMA of 10.70, and 200‑day SMA of 11.06, signaling a short‑term price weakness. The RSI of 45 is neutral, while the MACD line sits under its signal line, producing a bearish histogram and reinforcing the downside bias. Volume has been decreasing and 30‑day volatility is unusually high at 76%, though beta is modest at 0.83, suggesting the stock moves less than the market but is currently volatile. The price is near the identified support of $10.26 and faces resistance around $12.48, giving a tight trading range in the near term.
On the valuation side, a DCF model places fair value at $14.46, implying a 55% upside from current levels. The stock trades at a low price‑to‑book of 0.80 and a forward P/E of 18.5, while trailing earnings are negative but forward EPS is projected at $0.58. Free cash flow is positive at $12.2 M despite negative operating cash flow, and the balance sheet shows modest net debt after accounting for $17.4 M cash against $41.3 M debt. No dividend is paid, and the company’s operating margins remain in the red, highlighting earnings risk even as valuation multiples appear attractive.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Price hovering just above key support
  • Bearish MACD and decreasing volume
  • High short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • DCF upside of ~55% and low P/B ratio
  • Forward EPS turning positive
  • Manageable debt level with net cash position

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Industry demand for protective apparel
  • Potential earnings turnaround reflected in forward metrics
  • Undervalued relative to intrinsic fair value

Key Metrics & Analysis

Financial Health

Revenue Growth1.40%
Profit Margin-10.88%
P/E Ratio18.5
ROE-15.35%
ROA-2.04%
Debt/Equity31.65
P/B Ratio0.8
Op. Cash Flow$-5108000
Free Cash Flow$12.2M

Technical Analysis

TrendNeutral
RSI45.0
Support$10.26
Resistance$12.48
MA 20$11.26
MA 50$10.70
MA 200$11.06
MACDBearish
VolumeDecreasing
Fear & Greed Index86.36

Valuation

Fair Value$14.46
Target Price$16.50
Upside/Downside55.00%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.83
Volatility76.08%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.